400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Summary
The fund seeks to replicate the total return performance of the benchmark index before fees and expenses by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
As part of its strategy, the fund employs a passive or indexin More
Webiste
Directors
Jun 14, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Charles Park
Price
- $ 52.64 ( +1.11 )
-
Dec 09, 2024Last Close
- Net Assets
-
$0.9B
Feb 23, 2024
- 52-Week High/Low
- $55.7 - $51.1
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-80.68%
5 Year
-73.01%
Best
36.58%
2013
Worst
-80.48%
2024
Company Name |
Holding |
| UNITEDHEALTH GROUP INCORPORATED | 23.2 % |
| ELEVANCE HEALTH, INC. | 14.81 % |
| THE CIGNA GROUP | 7.82 % |
| HUMANA INC. | 4.76 % |
| CVS HEALTH CORPORATION | 4.42 % |
| CENTENE CORPORATION | 4.4 % |
| VEEVA SYSTEMS INC. | 4.35 % |
| HCA HEALTHCARE, INC. | 4.23 % |
| MOLINA HEALTHCARE, INC. | 2.96 % |
| LABCORP HOLDINGS INC. | 2.91 % |
| More | 2.91 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IHF | 0% | -80.5% | -1.9% | -7.6% | 24.2% | 16.2% | 21.6% | 9.6% | 25.5% | 1% | |
| S&P 500 | -10.3% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | -79.2% | -7.7% | -2.3% | 7.3% | -17% | 1.7% | 0.8% | 7.1% | -1.9% | ||||
| q2 | 0% | -3.7% | 3.5% | -9.7% | 6.5% | 15.8% | 1.7% | 12.8% | 10.9% | 4.5% | ||||
| q3 | 0% | 0% | -3.8% | 0% | -4% | 4.2% | -5.5% | 13.2% | -0.5% | -2.6% | ||||
| q4 | 0% | 0% | 6% | 4.8% | 13.5% | 16% | 24.2% | -14.3% | 5.4% | 1.1% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | -80.2% | 1.9% | 3% | -5% | 1.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |